SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004437
Filing Date
2022-03-28
Accepted
2022-03-28 09:53:21
Documents
107
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K casi-20211231x10k.htm   iXBRL 10-K 2560783
2 EX-21 casi-20211231xex21.htm EX-21 3638
3 EX-23.1 casi-20211231xex23d1.htm EX-23.1 2438
4 EX-31.1 casi-20211231xex31d1.htm EX-31.1 9823
5 EX-31.2 casi-20211231xex31d2.htm EX-31.2 10280
6 EX-32.1 casi-20211231xex32d1.htm EX-32.1 6153
7 EX-32.2 casi-20211231xex32d2.htm EX-32.2 6215
8 GRAPHIC casi-20211231x10k001.jpg GRAPHIC 4756
  Complete submission text file 0001558370-22-004437.txt   11650285

Data Files

Seq Description Document Type Size
9 EX-101.SCH casi-20211231.xsd EX-101.SCH 90190
10 EX-101.CAL casi-20211231_cal.xml EX-101.CAL 79133
11 EX-101.DEF casi-20211231_def.xml EX-101.DEF 340216
12 EX-101.LAB casi-20211231_lab.xml EX-101.LAB 618960
13 EX-101.PRE casi-20211231_pre.xml EX-101.PRE 575080
101 EXTRACTED XBRL INSTANCE DOCUMENT casi-20211231x10k_htm.xml XML 2198089
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 22773492
SIC: 2836 Biological Products, (No Diagnostic Substances)